CD274 and non-small cell lung carcinoma: Secondly, our study was single-centered and retrospective; besides, we performed PD-L1 testing in NSCLC patients with liver metastases for whom pathological tissue was available, which may account for the difference in PD-L1 expression between patients with and without liver metastases.